ホーム › 過体重 › バージニア

バージニアにおける過体重の臨床試験

バージニア内の拠点で、過体重に関する33件の研究が参加者を募集しています。

バージニア内の都市

公式研究テキスト（英語）

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Washington Center For Weight Management And Research /ID# 282047, Arlington
Sovah Health - Danville /ID# 282876, Danville
Health Research Of Hampton Roads /ID# 282014, Newport News
他1件

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

National Clin Res Inc., Richmond

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Washington Cntr Weight Mgmt, Arlington
Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

National Clin Res Inc., Richmond
Gastroent Consult of SW VA, Roanoke

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Sovah Clinical Research-River District, Danville
Clinical Research Partners, LLC, Richmond

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

York Clinical Research, LLC, Norfolk

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Research Site, Manassas

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

VCU Health - Center for Endocrinology Diabetes and Metabolism, Richmond

被験者募集中第3相

6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Gastroenterology Consultants of Southwest Virginia, Roanoke

被験者募集中第3相

18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

AMR Clinical, Norfolk

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Inova Cardiology - Fairfax, Fairfax
Virginia Heart, Falls Church

被験者募集中第3相

45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07589608

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Charlottesville Medical Research, Charlottesville

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07353931

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Manassas
Research Site, Norfolk

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Hampton

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Hampton

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Manassas Clinical Research Center, Manassas
Centricity Research Suffolk Primary Care, Suffolk

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Burke
ACCOMPLISH-2 Research Site, Manassas
ACCOMPLISH-2 Research Site, Suffolk

被験者募集中第3相健康なボランティア歓迎

18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Selma Medical Associates, Winchester

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/09更新 · NCT07770841

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Eastern Virginia Medical School (EVMS) Medical Group, Norfolk
Clinical Research Partners, LLC, Richmond

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT07215559

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sovah Clinical Research-River District, Danville

被験者募集中第2相

18歳〜75歳 · 全性別 · 2026/09/08更新 · NCT06143956

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

Health Res of Hampton Roads, Newport News
National Clin Res Inc., Richmond
Selma Medical Associates, Winchester

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/04更新 · NCT07745504

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Danville

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Washington Center for Weight Management and Research, Inc, Arlington
Health Research of Hampton Roads, Newport News
Selma Medical Associates, Winchester

被験者募集中第3相

18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Manassas Clinical Research Center Inc, Manassas

被験者募集中第3相

18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Manassas
Kailera Clinical Site, Richmond

被験者募集中第3相

18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Arlington

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/25更新 · NCT07784725

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Health Res of Hampton Roads, Newport News

被験者募集中第3相

18歳以上 · 全性別 · 2026/08/17更新 · NCT07509307

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

Children's Hospital of Richmond at VCU Healthy Lifestyles Center, Henrico

被験者募集中健康なボランティア歓迎

4歳以上 · 全性別 · 2026/06/10更新 · NCT06714929

Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 Diabetes

University of Virginia, Charlottesville

被験者募集中健康なボランティア歓迎

21歳〜50歳 · 全性別 · 2026/05/07更新 · NCT07573228

Examining Valence-based Effects in Self-Monitoring Feedback Messages

University of Virginia, Charlottesville

被験者募集中健康なボランティア歓迎

18歳以上 · 全性別 · 2026/03/31更新 · NCT07292389

Role of Microvascular Insulin Resistance and Cardiorespiratory Fitness Diabetes

University of Virginia, Charlottesville

被験者募集中健康なボランティア歓迎

30歳〜55歳 · 全性別 · 2026/03/23更新 · NCT04791371

Associations Between the Microbiome, Skeletal Muscle Perfusion, and Fitness Status

UVA Student Health and Wellness Building, Charlottesville

被験者募集中観察研究

18歳以上 · 全性別 · 2025/12/24更新 · NCT06009276

ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。